Dr. Matthew Lunning, DO
Claim this profileUniversity of Nebraska Medical Center
Studies Non-Hodgkin's Lymphoma
Studies Diffuse Large B-Cell Lymphoma
13 reported clinical trials
40 drugs studied
Area of expertise
1Non-Hodgkin's Lymphoma
MYC positive
BCL2 positive
BCL6 positive
2Diffuse Large B-Cell Lymphoma
MYC positive
BCL2 positive
BCL6 positive
Affiliated Hospitals
Clinical Trials Matthew Lunning, DO is currently running
Cell Therapy
for Non-Hodgkin's Lymphoma
This trial tests a new treatment where a patient's own immune cells are enhanced to fight difficult-to-treat lymphoma. It targets patients whose cancer hasn't responded to at least two other treatments. The modified cells aim to better recognize and attack the cancer. This new method improves the ability of the patient's immune cells to find and destroy cancer cells.
Recruiting1 award Phase 219 criteria
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting1 award Phase 2 & 3
More about Matthew Lunning, DO
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Matthew Lunning, DO has experience with
- Cyclophosphamide
- Prednisone
- Doxorubicin
- Rituximab
- Vincristine
- Etoposide
Breakdown of trials Matthew Lunning, DO has run
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Lymphoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Lunning, DO specialize in?
Matthew Lunning, DO focuses on Non-Hodgkin's Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Non-Hodgkin's Lymphoma has involved MYC positive patients, or patients who are BCL2 positive.
Is Matthew Lunning, DO currently recruiting for clinical trials?
Yes, Matthew Lunning, DO is currently recruiting for 4 clinical trials in Omaha Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Matthew Lunning, DO has studied deeply?
Yes, Matthew Lunning, DO has studied treatments such as Cyclophosphamide, Prednisone, Doxorubicin.
What is the best way to schedule an appointment with Matthew Lunning, DO?
Apply for one of the trials that Matthew Lunning, DO is conducting.
What is the office address of Matthew Lunning, DO?
The office of Matthew Lunning, DO is located at: University of Nebraska Medical Center, Omaha, Nebraska 10065 United States. This is the address for their practice at the University of Nebraska Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.